id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0223-0002,FDA,FDA-2002-D-0223,Guideline,Supporting & Related Material,GDL-Guidance,2003-12-12T05:00:00Z,2003,12,,,2008-04-12T01:17:31Z,,0,0,09000064804971f1